The diversity of young adult wheeze: a cluster analysis in a longitudinal birth cohort

Summary Background Cluster analyses have enhanced understanding of the heterogeneity of both paediatric and adult wheezing. However, while adolescence represents an important transitional phase, the nature of young adult wheeze has yet to be clearly characterised. Objectives To use cluster analysis...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental allergy Vol. 44; no. 5; pp. 724 - 735
Main Authors Kurukulaaratchy, R. J., Zhang, H., Raza, A., Patil, V., Karmaus, W., Ewart, S., Arshad, S. H.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.05.2014
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN0954-7894
1365-2222
1365-2222
DOI10.1111/cea.12306

Cover

Loading…
More Information
Summary:Summary Background Cluster analyses have enhanced understanding of the heterogeneity of both paediatric and adult wheezing. However, while adolescence represents an important transitional phase, the nature of young adult wheeze has yet to be clearly characterised. Objectives To use cluster analysis to define, for the first time, clinically relevant young adult wheeze clusters in a longitudinal birth cohort. Methods K‐means cluster analysis was undertaken among 309 currently wheezing subjects at 18 years in the Isle of Wight birth cohort (N = 1456). Thirteen disease‐characterising clustering variables at 18 years were used. Resulting clusters were then further characterised by severity indices plus potential risk factors for wheeze development throughout the 1st 18 years of life. Results Six wheeze clusters were identified. Cluster 1 (12.3%) male‐early‐childhood‐onset‐atopic‐wheeze‐with‐normal‐lung‐function had male predominance, normal spirometry, low bronchodilator reversibility (BDR), intermediate bronchial hyper‐responsiveness (BHR), high atopy prevalence and more admissions. Cluster 2 (24.2%) early‐childhood‐onset‐wheeze‐with‐intermediate‐lung‐function had no specific sex association, intermediate spirometry, BDR, BHR, more significant BTS step therapy and admissions. Cluster 3 (9.7%) female‐early‐childhood‐onset‐atopic‐wheeze‐with‐impaired‐lung‐function showed female predominance, high allergic disease comorbidity, more severe BDR and BHR, greatest airflow obstruction, high smoking prevalence, higher symptom severity and admissions. Cluster 4 (19.4%) female‐undiagnosed‐wheezers had adolescent‐onset non‐atopic wheeze, low BDR and BHR, impaired but non‐obstructed spirometry, high symptom frequency and highest smoking prevalence. Cluster 5 (24.6%) female‐late‐childhood‐onset‐wheeze‐with‐normal‐lung‐function showed no specific atopy association, normal spirometry, low BDR, BHR and symptom severity. Cluster 6 (9.7%) male‐late‐childhood‐onset‐atopic‐wheeze‐with‐impaired‐lung‐function had high atopy and rhinitis prevalence, increased BDR and BHR, moderately impaired spirometry, high symptom severity and higher BTS step therapy. Conclusions and Clinical Relevance Young adult wheeze is diverse and can be classified into distinct clusters. More severe clusters merit attention and are associated with childhood onset, atopy, impaired lung function and in some, smoking. Smoking‐associated undiagnosed wheezers also merit recognition. Better understanding of young adult wheeze could facilitate better later adult respiratory health.
Bibliography:istex:87E63AD39F4F4823EE85AE8C0FAD96BBD705A801
ark:/67375/WNG-DT6JSP53-C
Data S1. Supplementary methods details. Table S1. The correlations between the 10 continuous clustering variables. Table S2. Biserial correlations between continuous and binary outcome variables. TableS3. Biserial correlations between the binary outcome variables. Table S4. Pseudo F, R2 and CCC for different number of clusters in model. Table S5. Characteristics of participants attending for a full visit at 18 years versus the whole population seen at 18 years. Table S6. Standardised variables.
ArticleID:CEA12306
National Institutes of Health USA - No. R01 HL082925
National Institute of Allergy and Infectious Diseases - No. R01 AI091905; No. R21 AI099367
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:0954-7894
1365-2222
1365-2222
DOI:10.1111/cea.12306